The synthesis of a labile triosephosphate isomerase isozyme in human lymphoblasts and fibroblasts.
D002238:Carbohydrate Epimerases / Q000096:biosynthesis*; D004247:DNA / Q000096:biosynthesis; D003609:Dactinomycin / Q000494:pharmacology; D005260:Female; D005347:Fibroblasts / Q000201:enzymology*; D006146:Guanidines / Q000494:pharmacology; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology; D007527:Isoenzymes / Q000302:isolation & purification; D007930:Leucine / Q000378:metabolism; D008214:Lymphocytes / Q000187:drug effects / Q000201:enzymology*; D010920:Placenta / Q000201:enzymology; D011247:Pregnancy; D014176:Protein Biosynthesis; D011691:Puromycin / Q000494:pharmacology; D012313:RNA / Q000096:biosynthesis; D014305:Triose-Phosphate Isomerase / Q000096:biosynthesis* / Q000302:isolation & purification
D006146:Guanidines; D007527:Isoenzymes; D003609:Dactinomycin; D011691:Puromycin; D012313:RNA; D004247:DNA; D002238:Carbohydrate Epimerases; D014305:Triose-Phosphate Isomerase; D007930:Leucine; D006918:Hydroxyurea